Incidence of cancer among female patients with systemic lupus erythematosus in Korea

Clinical Rheumatology

Volumn 29, Issue 4, 2010, Pages 381-388

  Kang, Kwi Young ^a   Kim, Hyun Ok ^a   Yoon, Ho Sung ^a   Lee, Jeniffer ^a   Lee, Won Chul ^b   Ko, Hyek Jae ^a   Ju, Ji Hyeon ^a   Cho, Chul Soo ^a   Kim, Ho Youn ^a   Park, Sung Hwan ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Bladder cancer; Cancer; Cyclophosphamide; Non Hodgkin's lymphoma (NHL); Standardized incidence ratio (SIR); Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE;

ADULT; ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KOREA; NONHODGKIN LYMPHOMA; ONSET AGE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NEOPLASMS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77950865019     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1332-7     Document Type: Article

References (38)

1. M Merrel LE Shulman 1995 Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus J Chronic Dis 1 12 32 10.1016/0021-9681(55)90018-7
2. M Pistiner DJ Wallace S Nessim, et al. 1991 Lupus erythematosus in the 1980s: a survey of 570 patients Semin Arthritis Rheum 21 55 64 10.1016/0049-0172(91)90057-7 1:STN:280:DyaK38%2FlsVKgsw%3D%3D 1948102
3. R Cervera MA Khamashta J Font, et al. 2003 Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestation in a cohort of 1,000 patients Medicine 82 299 308 10.1097/01.md.0000091181.93122.55 14530779 (Pubitemid 37229465)
4. M Gripenberg T Helve 1991 Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with reference to the predictive value of anti n-DNA antibody determination Scand J Rheumatol 20 104 109 10.3109/ 03009749109165284 1:STN:280:DyaK3M3jtlehtw%3D%3D 2031153
5. A Doria L Iaccarino A Ghirardello S Zampieri S Arienti P Sarzi-Puttini F Atzeni A Piccoli S Todesco 2006 Long-term prognosis and causes of death in systemic lupus erythematosus Am J Med 119 700 706 10.1016/j.amjmed.2005.11.034 16887417 (Pubitemid 44128446)
6. S Bernatsky JF Boivin L Joseph S Manzi E Ginzler DD Gladman M Urowitz PR Fortin M Petri S Barr C Gordon SC Bae D Isenberg A Zoma C Aranow MA Dooley O Nived G Sturfelt K Steinsson G Alarcón JL Senécal M Zummer J Hanly S Ensworth J Pope S Edworthy A Rahman J Sibley H El-Gabalawy T McCarthy Y St Pierre A Clarke R Ramsey-Goldman 2006 Mortality in systemic lupus erythematosus Arthritis Rheum 54 2550 2557 10.1002/art.21955 1:STN:280:DC%2BD28rgvFOrtw%3D%3D 16868977 (Pubitemid 44205016)
7. KE Moss Y Ioannou SM Sultan I Haq DA Isenberg 2002 Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades Ann Rheum Dis 61 409 413 10.1136/ard.61.5.409 1:STN:280:DC%2BD383it1Chug%3D%3D 11959764 (Pubitemid 34496819)
8. S Bernatsky JF Boivin L Joseph R Rajan A Zoma S Manzi E Ginzler M Urowitz D Gladman PR Fortin M Petri S Edworthy S Barr C Gordon SC Bae J Sibley D Isenberg A Rahman C Aranow MA Dooley K Steinsson O Nived G Sturfelt G Alarcón JL Senécal M Zummer J Hanly S Ensworth J Pope H El-Gabalawy T McCarthy Y St Pierre R Ramsey-Goldman A Clarke 2005 An international cohort study of cancer in systemic lupus erythematosus Arthritis Rheum 52 1481 1490 10.1002/art.21029 1:STN:280:DC%2BD2M3ks1Gjsg%3D%3D 15880596 (Pubitemid 40663940)
9. A Parikh-Patel RH White M Allen R Cress 2008 Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California Cancer Causes Control 19 887 894 10.1007/s10552-008-9151-8 18386139
10. J Cibere J Sibley M Haga 2001 Systemic lupus erythematosus and the risk of malignancy Lupus 10 394 400 10.1191/096120301678646128 1:STN:280: DC%2BD38%2FhslWgsA%3D%3D 11434573 (Pubitemid 32578613)
11. L Bjornadal B Lofstrom L Yin I Lundberg A Ekbom 2002 Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus Scand J Rheumatol 31 66 71 10.1080/03009740252937568 12109649 (Pubitemid 34518083)
12. T Pettersson E Pukkala L Teppo C Friman 1992 Increased risk of cancer in patients with systemic lupus erythematosus Ann Rheum Dis 51 437 439 10.1136/ard.51.4.437 1:STN:280:DyaK383msVyiuw%3D%3D 1586239
13. M Abu-Shakra DD Gladman MB Urowitz 1996 Malignancy in systemic lupus erythematosus Arthritis Rheum 39 1050 1054 10.1002/art.1780390625 1:STN:280:DyaK283jt1Cgug%3D%3D 8651970 (Pubitemid 26182076)
14. SM Sultan Y Ioannou DA Isenberg 2000 Is there an association of malignancy with SLE? An analysis of 276 patients under long-term review Rheumatology 39 1147 1152 10.1093/rheumatology/39.10.1147 1:STN:280: DC%2BD3M%2FjtlKntg%3D%3D 11035137
15. O Nived A Bengtsson A Jonsen G Sturfelt H Olsson 2001 Malignancies during follow-up in an epidemiologically defined SLE inception cohort in southern Sweden Lupus 10 500 504 10.1191/096120301678416079 1:STN:280: DC%2BD38%2Fis1ynuw%3D%3D 11480849 (Pubitemid 32675051)
16. BC Chun SC Bae 2005 Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea Lupus 14 635 638 10.1191/0961203305lu2180xx 16175938 (Pubitemid 41297003)
17. T Tarr B Gyorfy E Szekanecz HP Bhattoa M Zeher G Szegedi E Kiss 2007 Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center Ann N Y Acad Sci 1108 76 82 10.1196/annals.1422.008 17893972 (Pubitemid 47528719)
18. O Ragnarsson G Gröndal K Steinsson 2003 Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus Lupus 12 687 691 10.1191/0961203303lu443oa 1:STN:280:DC%2BD3svltlejtg%3D%3D 14514131 (Pubitemid 37173665)
19. MC Hochberg 1997 Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725 10.1002/art.1780400928 1:STN:280:DyaK2svmsVaisw%3D%3D 9324032
20. DA Isenberg DD Gladman 2001 The systemic lupus international collaborating clinics group: origins and outcomes Lupus 10 375 377 10.1191/096120301676101377 1:STN:280:DC%2BD3MzjsF2ltQ%3D%3D 11403271 (Pubitemid 32520246)
21. Incidence in Korea 1999-2001 (2005) Ministry of Health and Welfare, Republic of Korea
22. S Bernatsky JF Boivin L Joseph S Manzi E Ginzler M Urowitz D Gladman P Fortin C Gordon S Barr S Edworthy SC Bae M Petri J Sibley D Isenberg A Rahman K Steinsson C Aranow MA Dooley GS Alarcon J Hanly G Sturfelt O Nived J Pope S Ensworth R Rajan H El-Gabalawy T McCarthy Y St Pierre A Clarke R Ramsey-Goldman 2005 Race/ethnicity and cancer occurrence in systemic lupus erythematosus Arthritis Rheum 53 781 784 10.1002/art.21458 1:STN:280:DC%2BD2MrlvV2hsA%3D%3D 16208671 (Pubitemid 41463845)
23. L Mellemkjer V Andersen MS Linet G Gridley R Hoover JH Olsen 1997 Non-Hodgkin's lymphoma and other cancers among a cohort of patients with SLE Arthritis Rheum 40 761 768 10.1002/art.1780400424 (Pubitemid 27157584)
24. A Hansen PE Lipsky T Dörner 2007 B-cell lymphoproliferation in chronic inflammatory rheumatic diseases Nat Clin Pract Rheumatol 3 561 569 10.1038/ncprheum0620 1:CAS:528:DC%2BD2sXhtV2msbnK 17906611 (Pubitemid 47514471)
25. P Youinou, et al. 2006 B lymphocytes in the front line of autoimmunity Autoimmun Rev 5 215 221 10.1016/j.autrev.2005.06.011 16483922 (Pubitemid 43239477)
26. PE Lipsky 2001 Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity Nat Immunol 2 764 766 10.1038/ni0901-764 1:CAS:528: DC%2BD3MXmsFeju7s%3D 11526379
27. T Dörner PE Lipsky 2002 Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome Arthritis Res 4 360 371 10.1186/ar603 12453312 (Pubitemid 35364004)
28. M Abu-Shakra M Ehrenfeld Y Shoenfeld 2002 Systemic lupus erythematosus and cancer: associated or not? Lupus 11 137 144 10.1191/0961203302lu182rr 1:CAS:528:DC%2BD38XjsFGisbc%3D 11999878 (Pubitemid 34296928)
29. S Bernatsky L Joseph JF Boivin C Gordon M Urowitz D Gladman PR Fortin E Ginzler SC Bae S Barr S Edworthy D Isenberg A Rahman M Petri GS Alarcón C Aranow MA Dooley R Rajan JL Sénécal M Zummer S Manzi R Ramsey-Goldman AE Clarke 2008 The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study Ann Rheum Dis 67 74 79 10.1136/ard.2006.069039 1:STN:280:DC%2BD2sjjslKmsw%3D%3D 17545189
30. SK Chow LM Looi CS Loh SS Yeap 2002 Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis Intern Med J 32 114 116 10.1046/j.1445-5994.2002.00172.x 1:STN:280:DC%2BD387lsVagtA%3D%3D 11885838
31. A Ortiz E Gonzalez-Parra G Alvarez-Costa J Egido 1992 Bladder cancer after cyclophosphamide therapy for lupus nephritis Nephron 60 378 379 10.1159/000186790 1:STN:280:DyaK383ivVSqsg%3D%3D 1565199
32. JB Thrasher GJ Miller JN Wettlaufer 1990 Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis J Urol 143 119 121 1:STN:280:DyaK3c%2Fps1agsw%3D%3D 2294239
33. JJ Canoso AS Cohen 1974 Malignancy in a series of 70 patients with systemic lupus erythematosus Arthritis Rheum 17 383 390 10.1002/art.1780170407 1:STN:280:DyaE2czgsVagtw%3D%3D 4604718
34. VM Ognenovski W Marder EC Somers CM Johnston JG Farrehi SM Selvaggi WJ McCune 2004 Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide J Rheumatol 31 1763 1767 1:CAS:528:DC%2BD2cXosVKls78%3D 15338497 (Pubitemid 39202518)
35. M Lopez Dupla M Khamashta V Pintado Garcia P Lavilla Uriol E Valencia Ortega A Gil Aguado 1993 Malignancy in systemic lupus erythematosus: a report of five cases in a series of 96 patients Lupus 2 377 380 10.1177/ 096120339300200608 1:STN:280:DyaK2c7osVemsg%3D%3D 8136821 (Pubitemid 24017338)
36. McCune WJ, Riskalla M (2002) Immunosuppressive drug therapy. In: Wace DJ, Hahn B (eds) Dubois' lupus erythematosus, 6th edn. Linppincott Williams & Wilkins, Philadelphia, pp 1195-1217
37. P Asten J Barrett D Symmons 1999 Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases J Rheumatol 26 1705 1714 1:CAS:528:DyaK1MXltlOms7Y%3D 10451066 (Pubitemid 29367309)
38. CK Wells PN Peduzzi AR Feinstein 2001 Presenting manifestations, cigarette smoking, and detection bias in age at diagnosis of lung cancer Ann Epidemiol 11 239 247 10.1016/S1047-2797(00)00213-1 1:STN:280: DC%2BD3MzntVansg%3D%3D 11306342 (Pubitemid 32293542)